Translate this page into:
Letter to the Editor
doi:
10.4103/0972-3919.223249
Reply by Author
Copyright: © 2018 Indian Journal of Nuclear Medicine
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Dear Sir,
Thank you very much for reading our article and your positive comments thereof.
Although you are in sync with our thought process of using the FDG PET in the scenario of discussed cases, your suggestion to do a larger prospective series is welcome. One scientific point that might be considered is the use of 18F-FLT. It is more marrow specific and in leukemias may add to be more specific.